Ergoset (bromocriptine) causes weight loss of 13.9 lbs in four months vs 2 lbs

Posted by .(JavaScript must be enabled to view this email address)
Thursday, October 15, 2009 12:47 pm Email this article
People given Ergoset, a quick-release form of bromocriptine, lost an average of 13.9 pounds in four months versus 2 pounds for those given a placebo according to a 1996 study. Subjects

Subjects: 17 obese people

The study involved 17 obese people of which 5 were mildly diabetic.

 

Dose and Timing

Dose and Timing of the Drug: 1.6 to 2.4 mg given at 8:00 AM

They were given 1.6 to 2.4 mg of Ergoset daily at 8:00 AM or a placebo.

 

Diet

Diet: Calories reduced 30% below needs

They were told to follow a moderately-resticted diet containing 30 percent fewer calories than their needs.

 

Body Fat

85% of weight loss was body fat

Eighty-five percent of the weight loss in the drug group was fat (11.9 lbs).

 

Glucose Tolerance and Insulin

Glucose Tolerance improved 46%; Insulin secretion reduced 30%

The Ergoset group also had a 46 percent improvement in glucose tolerance and a 30 percent reduction in insulin secretion.

REFERENCE

Cincotta A, Meier A. Bromocriptine (ergoset) reduces body weight and improves glucose tolerance in obese subjects. Diabetes Care. 1996 Jun, 19(6):667-70.

AUTHOR’S CONTACT INFORMATION

Ergo Science
Charlestown, Massachusetts 02129, USA

Articles on the same subject can be found here:

• Bromocriptine (Ergoset)